Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway
Scutellaria baicalensis has been reported to improve the lipid metabolism of high-fat diet-induced liver dysfunction, but direct evidence is rare. This study aimed to explore the effects and mechanisms of S. baicalensis and its major constituent baicalin on hepatic lipotoxicity. KK-Ay mice and orotic acid (OA)-induced nonalcoholic fatty liver disease (NAFLD) rats were used to evaluate lipid metabolism regulatory effects. Sodium oleate-induced triglyceride-accumulated HepG2 cells were used for the mechanism study, pretreated with or without compound C or STO-609 or transfected with liver kinase B1 (LKB1) siRNA. In KK-Ay mice, S. baicalensis extract showed a decreased effect on serum and hepatic triglycerides, total cholesterols, and free fatty acid (FFA) levels after 8 weeks of treatment. In OA-induced NAFLD rats, 18 days of treatment with baicalin significantly inhibited hepatic lipid accumulation, attenuating hepatocyte hypertrophy, vacuolization and necrosis. S. baicalensis and baicalin treatment significantly suppressed the sterol regulatory element binding protein-1c (SREBP-1c) transcriptional program with downregulation of gene and protein expression of SREBP-1c (both precursor and mature fraction) and acetyl-CoA carboxylase, fatty acid synthase and stearoyl-CoA desaturase, and upregulation of AMP-activated protein kinase (AMPK), carnitine palmitoyl transferase 1 and nuclear respiratory factor 2 in the liver. Furthermore, activation of AMPK by baicalin was observed to be relative to the increase in phosphorylation of calmodulin-dependent protein kinase kinase. Taken together, S. baicalensis conferred preventive effects against FFA-induced lipotoxicity through the AMPK-mediated SREBP signaling pathway.
KeywordsScutellaria baicalensis Baicalin FFAs AMPK-mediated SREBP signaling SREBP-1c translocation Lipotoxicity
This research was supported by the National Natural Science Foundation of China (81430095; 81673703; 81173524), Important Drug Development Fund, Ministry of Science and Technology of China (2017ZX09305–002).
- 2.Meng G, Zhang B, Yu F, Li C, Zhang Q, Liu L, Wu H, Xia Y, Bao X, Shi H, Su Q, Gu Y, Fang L, Yang H, Yu B, Sun S, Wang X, Zhou M, Jia Q, Jiao H, Wang B, Guo Q, Carvalhoa L, Sun Z, Song K, Yu M, Niu K (2017) Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population. Eur J Nutr. https://doi.org/10.1007/s00394-017-1485-0 Google Scholar
- 8.Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Gene Dev 14(22):2819–2830CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Javary Joaquim, Allain-Courtois Nathalie, Saucisse Nicolas, Costet Pierre, Heraud Capucine, Benhamed Fadila, Pierre Rémi, Bure Corinne, Pallares-Lupon Nestor, Cruzeiro Marcio Do, Postic Catherine, Cota Daniela, Dubus Pierre, Rosenbaum Jean, Benhamouche-Trouillet S (2017) Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling. Gut. https://doi.org/10.1136/gutjnl-2017-314208 PubMedGoogle Scholar
- 11.He MY, Deng YX, Shi QZ, Zhang XJ, Lv Y (2014) Comparative pharmacokinetic investigation on baicalin and wogonoside in type 2 diabetic and normal rats after oral administration of traditional Chinese medicine Huanglian Jiedu decoction. J Ethnopharmacol 155(1):334–342. https://doi.org/10.1016/j.jep.2014.05.033 CrossRefPubMedGoogle Scholar
- 15.Guo HX, Liu DH, Ma Y, Liu JF, Wang Y, Du ZY, Wang X, Shen JK, Peng HL (2009) Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet. Acta Pharmacol Sin 30(11):1505–1512. https://doi.org/10.1038/aps.2009.150 CrossRefPubMedPubMedCentralGoogle Scholar
- 16.Xi Y, Wu M, Li H, Dong S, Luo E, Gu M, Shen X, Jiang Y, Liu Y, Liu H (2015) Baicalin attenuates high fat diet-induced obesity and liver dysfunction: dose-response and potential role of CaMKKbeta/AMPK/ACC pathway. Cell Physiol Biochem 35(6):2349–2359. https://doi.org/10.1159/000374037 CrossRefPubMedGoogle Scholar
- 23.Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, Gao B, Wierzbicki M, Verbeuren TJ, Shaw RJ, Cohen RA, Zang M (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13(4):376–388. https://doi.org/10.1016/j.cmet.2011.03.009 CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Qing-ming C, Xin-li H, Yan-mei L, Zhang K, Akao T, Tori MH (2001) Studies on metabolites of baicalin in human urine. China J Chin Mater Med 26(11):768–769Google Scholar
- 25.Zhang J, Cai W, Zhou Y, Liu Y, Wu X, Li Y, Lu J, Qiao Y (2015) Profiling and identification of the metabolites of baicalin and study on their tissue distribution in rats by ultra-high-performance liquid chromatography with linear ion trap-Orbitrap mass spectrometer. J Chromatogr B 985:91–102. https://doi.org/10.1016/j.jchromb.2015.01.018 CrossRefGoogle Scholar
- 30.Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y, Sakashita Y, Kobashi K (2000) Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol 52(12):1563–1568CrossRefPubMedGoogle Scholar
- 37.Zeng X, Yang J, Hu O, Huang J, Ran L, Chen M, Zhang Y, Zhou X, Zhu J, Zhang Q, Yi L, Mi M (2018) Dihydromyricetin ameliorates nonalcoholic fatty liver disease by improving mitochondrial respiratory capacity and redox homeostasis through modulation of SIRT3 signaling. Antioxid Redox Sign. https://doi.org/10.1089/ars.2017.7172 Google Scholar